Sorrento Therapeutics, Inc.

SRNEDelisted Apr 12, 2023

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000850261

SEC filings (opens in a new tab)

Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Sorrento Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of SRNE: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	212	4	221	+13
Shares	77.5M	339.2K	86.1M	+8.95M (+11.6%)
Value	$750.9M	$3.29M	$657.9M	−$89.7M (−12.0%)

4 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Sorrento Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to SRNE in Q3 2021
Institution	Shares	Value	% of portfolio
Norges Bank	712,535	$5.44M	0.00%
Walleye Trading LLC	128,365	$979.0K	0.02%
Highland Capital Management Fund Advisors, L.P.	100,000	$763.0K	0.13%
Moloney Securities Asset Management, LLC	43,200	$330.0K	0.06%
Gsa Capital Partners LLP	35,363	$270.0K	0.03%
AXA S.A.	29,800	$227.0K	0.00%
GFG Capital, LLC	26,800	$204.0K	0.06%
Connor, Clark & Lunn Investment Management Ltd.	26,495	$202.0K	0.00%
First Republic Investment Management, Inc.	25,837	$197.0K	0.00%
E Fund Management Co., Ltd.	21,764	$166.0K	0.01%
Algert Global LLC	19,803	$151.0K	0.02%
Pictet Asset Management SA	19,066	$145.0K	0.00%
Perigon Wealth Management, LLC	18,200	$139.0K	0.01%
IFG Advisory, LLC	17,900	$136.0K	0.01%
Mackenzie Financial Corp	15,957	$122.0K	0.00%
TL Private Wealth	16,000	$108.0K	0.06%
Secure Asset Management, LLC	13,457	$103.0K	0.05%
Visionary Wealth Advisors	12,200	$93.0K	0.01%
Parametrica Management Ltd	11,058	$84.0K	0.06%
People's United Financial, Inc.	10,870	$83.0K	0.00%
Centiva Capital, LP	10,112	$77.0K	0.01%
Ieq Capital, LLC	10,182	$77.0K	0.00%
Sculptor Capital LP	8,600	$66.0K	0.00%
Russell Investments Group, Ltd.	3,200	$24.0K	0.00%
Meridian Wealth Partners, LLC	300	$2.00K	0.00%
Signaturefd, LLC	191	$1.00K	0.00%
Rockbridge Investment Management, LCC	100	$1.00K	0.00%
Dark Forest Capital Management LP	144	$1.00K	0.00%
Bell Investment Advisors, Inc	128	$1.00K	0.00%
Gerber Kawasaki Wealth & Investment Management	101	$0	0.00%
Hexagon Capital Partners LLC	1	$0	0.00%

Sold out (18)

Institutions that held Sorrento Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of SRNE in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Capital Fund Management S.A.	329,434	$3.19M
Millennium Management LLC	171,293	$1.66M
Hancock Whitney Corp	125,000	$1.21M
Sante Capital Fund, LP	80,414	$779.0K
ExodusPoint Capital Management, LP	76,327	$740.0K
Y-Intercept (Hong Kong) Ltd	49,546	$480.0K
Rathbone Brothers plc	40,784	$395.0K
Massachusetts Financial Services Co	26,973	$261.0K
Cubist Systematic Strategies, LLC	21,028	$204.0K
HighVista Strategies LLC	18,000	$174.0K
Capula Management Ltd	11,481	$111.0K
Neo Ivy Capital Management	6,668	$65.0K
Panagora Asset Management Inc	4,426	$43.0K
Paradigm, Strategies in Wealth Management, LLC	1,590	$15.0K
Creative Financial Designs Inc	500	$5.00K
FMR LLC	401	$4.00K
Trust Co of Vermont	204	$2.00K
Farmers & Merchants Trust Co of Chambersburg PA	25	$0

Not filed for Q3 2021 yet (4)

Institutions that held Sorrento Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SRNE in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Mayo Clinic	300,000	$2.91M
QS Investors, LLC	20,000	$194.0K
Pictet Asset Management Ltd	19,066	$185.0K
CWM, LLC	150	$1.00K